SCHEMBL2573208

SCHEMBL2573208

CCC/C=C/C=C/CCC(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FASN P49327 1/20 0.59
▸ PPARG P37231 4/20 0.54
▸ MAPT P10636 3/20 0.54
▸ CYP19A1 P11511 2/20 0.54
▸ FFAR1 O14842 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ RXRA P19793 1/20 0.54
▸ OXER1 Q8TDS5 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.49
▸ FFAR3 O14843 1/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ TERT O14746 3/20 0.47
▸ PTPN1 P18031 3/20 0.47
▸ PPARD Q03181 3/20 0.47
▸ PPARA Q07869 3/20 0.47
▸ FAAH O00519 3/20 0.47
▸ BLM P54132 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2573210 1.00 FASN (0.59) FASNPPARGMAPTCYP19A1FFAR1
SCHEMBL2441819 0.90 PPARG (0.64) PPARGMAPTCYP19A1FFAR1ALDH1A1
SCHEMBL586010 0.90 PPARG (0.64) PPARGMAPTCYP19A1FFAR1ALDH1A1
SCHEMBL1664949 0.90 PPARG (0.64) PPARGMAPTCYP19A1FFAR1ALDH1A1
SCHEMBL105841 0.88 ALDH1A1 (0.63) FASNPPARGMAPTCYP19A1FFAR1
SCHEMBL466118 0.88 PPARG (0.61) PPARGMAPTCYP19A1FFAR1ALDH1A1
SCHEMBL466117 0.88 PPARG (0.61) PPARGMAPTCYP19A1FFAR1ALDH1A1
SCHEMBL17473895 0.88 PPARG (0.61) PPARGMAPTCYP19A1FFAR1ALDH1A1
SCHEMBL11580321 0.87 ALDH1A1 (0.52) FASNPPARGMAPTCYP19A1FFAR1
SCHEMBL11580318 0.87 ALDH1A1 (0.52) FASNPPARGMAPTCYP19A1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200155575-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2020-05-21 — — US disclosed
US-20190269700-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2019-09-05 — — US disclosed
US-20180104257-A1 (17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use LIPOCINE INC. (US) 2018-04-19 — — US disclosed
US-20180078568-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2018-03-22 — — US disclosed
EP-3185873-A1 PHARMACEUTICAL COMPOSITION AND METHODS Lipocine Inc. (US) 2017-07-05 — — EP disclosed
US-20160193225-A1 (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE LIPOCINE INC. (US) 2016-07-07 — — US disclosed
US-20160184324-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2016-06-30 — — US disclosed
WO-2016033611-A1 (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE LIPOCINE INC. (US) 2016-03-03 — — WO disclosed
WO-2016033536-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2016-03-03 — — WO disclosed
WO-2015128428-A1 PHEROMONE DISPENSER MADE OF PLASTIC MATERIAL BASF SE (DE) 2015-09-03 — — WO disclosed
EP-2384111-A1 PHEROMONE DISPENSER BASF SE (DE) 2011-11-09 — — EP disclosed
WO-2010076316-A1 PHEROMONE DISPENSER BASF SE (DE) 2010-07-08 — — WO disclosed
Send feedback